imiquimod has been researched along with Allergic Contact Dermatitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Li, XZ; Liu, X; Tian, JY; Wang, Y; Xu, ZH; Yuan, M; Zhang, JC | 1 |
| Amagai, M; Iriki, H; Ito, H; Kurebayashi, Y; Mukai, M; Takahashi, H | 1 |
| Akira, S; Sano, S; Satoh, T; Takaishi, M | 1 |
3 other study(ies) available for imiquimod and Allergic Contact Dermatitis
| Article | Year |
|---|---|
Mechanisms of the PD-1/PD-L1 pathway in itch: From acute itch model establishment to the role in chronic itch in mouse.
Topics: Animals; B7-H1 Antigen; Dermatitis, Allergic Contact; Dinitrofluorobenzene; Disease Models, Animal; Imiquimod; Immune Checkpoint Inhibitors; Mice; Mice, Inbred C57BL; Programmed Cell Death 1 Receptor; Pruritus; Psoriasis; Spinal Cord Dorsal Horn | 2023 |
Imiquimod-induced dermatitis impairs thymic tolerance of autoreactive CD4
Topics: Animals; CD4-Positive T-Lymphocytes; Dermatitis, Allergic Contact; Desmoglein 3; Disease Models, Animal; Humans; Imiquimod; Immune Tolerance; Mice; Mice, Knockout; Pemphigus; Skin; Thymus Gland | 2020 |
Regnase-1, an Immunomodulator, Limits the IL-36/IL-36R Autostimulatory Loop in Keratinocytes to Suppress Skin Inflammation.
Topics: Animals; Cells, Cultured; Dermatitis, Allergic Contact; Dinitrofluorobenzene; Disease Models, Animal; Humans; Imiquimod; Immunologic Factors; Interleukin-1; Keratinocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Primary Cell Culture; Receptors, Interleukin-1; Ribonucleases; Signal Transduction; Skin | 2018 |